Cargando…

Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals

Cytomegalovirus (CMV) causes clinical issues primarily in immune-suppressed conditions. CMV-associated anterior uveitis (CMV-AU) is a notable new disease entity manifesting recurrent ocular inflammation in immunocompetent individuals. As patient demographics indicated contributions from genetic back...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yawata, Nobuyo, Shirane, Mariko, Woon, Kaing, Lim, Xinru, Tanaka, Hidenori, Kawano, Yoh-Ichi, Yawata, Makoto, Chee, Soon-Phaik, Siak, Jay, Sonoda, Koh-Hei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037729/ https://www.ncbi.nlm.nih.gov/pubmed/33807229 http://dx.doi.org/10.3390/ijms22073623

Ejemplares similares

Kinetics of Tear Fluid Proteins after Endothelial Keratoplasty and Predictive Factors for Recovery from Corneal Haze
por: Yawata, Nobuyo, et al.
Publicado: (2019)

CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis
por: Goodman, A. L., et al.
Publicado: (2014)

Acute Cytomegalovirus (CMV) Hepatitis in an Immunocompetent Adult
por: Zahid, Maleeha, et al.
Publicado: (2020)

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
por: Yawata, Makoto, et al.
Publicado: (2006)

Impact of CMV Infection on Natural Killer Cell Clonal Repertoire in CMV-Naïve Rhesus Macaques
por: Truitt, Lauren L., et al.
Publicado: (2019)

CMV Colitis Masquerading as MALT Lymphoma in an Immunocompetent Patient
por: Lam, Angela Y., et al.
Publicado: (2022)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature
por: Chiereghin, Angela, et al.
Publicado: (2021)

Development of Cytomegalovirus (CMV) Immune Recovery Uveitis Is Associated with Th17 Cell Depletion and Poor Systemic CMV-Specific T Cell Responses
por: Hartigan-O'Connor, Dennis J., et al.
Publicado: (2011)

Current aspects on the management of viral uveitis in immunocompetent individuals
por: Pleyer, Uwe, et al.
Publicado: (2015)

The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV
por: Carbone, Javier
Publicado: (2016)

CMV Colitis in Immunocompetent Patients: 2 Cases of a Diagnostic Challenge
por: Paparoupa, Maria, et al.
Publicado: (2016)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis
por: Wong, John X. H., et al.
Publicado: (2016)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals
por: Aichelburg, Maximilian C., et al.
Publicado: (2015)

Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
por: He, Ran, et al.
Publicado: (2011)

Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens
por: Deml, Ludwig, et al.
Publicado: (2021)

Protein-Loosing Entropathy Induced by Unique Combination of CMV and HP in an Immunocompetent Patient
por: Chen, S., et al.
Publicado: (2012)

Immune Recovery Uveitis Masked as an Endogenous Endophthalmitis in a Patient with Active CMV Retinitis
por: Figueiredo, Ligia, et al.
Publicado: (2013)

Efficacy and safety of an extemporaneous preparation of 2% ganciclovir eye drops in CMV anterior uveitis
por: Keorochana, Narumon, et al.
Publicado: (2017)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

HIV patients stable on ART retain evidence of a high CMV load but changes to Natural Killer cell phenotypes reflect both HIV and CMV
por: Affandi, Jacquita S., et al.
Publicado: (2015)

Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis
por: Frascaroli, Giada, et al.
Publicado: (2020)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines
por: Chang, W. L. William, et al.
Publicado: (2020)

Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection
por: Dobbins, G. Clement, et al.
Publicado: (2019)

THE PREVALENCE OF CYTOMEGALOVIRUS (CMV) VIRURIA AMONG HOSPITALIZED CHILDREN AND THE RISK OF CMV ACQUISITION BY NURSES
por: Adler, Stuart P, et al.
Publicado: (1984)

cmv1-Mediated Resistance to CMV in Melon Can Be Overcome by Mixed Infections with Potyviruses
por: Giordano, Andrea, et al.
Publicado: (2023)

Clinical profile of hearing loss in children with congenital cytomegalovirus (CMV) infection: CMV DNA diagnosis using preserved umbilical cord
por: Furutate, Sakiko, et al.
Publicado: (2011)

Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact
por: Valle-Arroyo, Jorge, et al.
Publicado: (2020)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation
por: Wang, Xiaodong, et al.
Publicado: (2021)

por: Yawata, Makoto, et al.
Publicado: (2006)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
por: Miele, Monica, et al.
Publicado: (2021)

γδ T cells take on CMV
por: Van Epps, Heather L.
Publicado: (2005)

CMV Oophoritis in an AIDS Patient
por: Albert, Michael S., et al.
Publicado: (1995)

CMV and Triggers of Systemic Sclerosis
Publicado: (2006)

CMV Pancreatitis in an Immunocompromised Patient
por: Ahmad, Jaffer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5qgkb7m5ra98jtkfcsd39v8tup